Trump going after health insurers to lower premiums
Seeking Alpha News (Fri, 19-Dec 3:42 PM ET)
Managed care stocks diverge in 2025: ALHC and OSCR rise while UNH, CNC slide
Seeking Alpha News (Fri, 19-Dec 6:50 AM ET)
Globe Newswire (Thu, 18-Dec 5:41 PM ET)
PRNewswire (Wed, 17-Dec 3:01 PM ET)
Sunshine Health Partners with Local Women Athletes to Champion Health Awareness
PRNewswire (Wed, 17-Dec 1:00 PM ET)
PRNewswire (Thu, 11-Dec 3:00 PM ET)
PRNewswire (Tue, 2-Dec 9:39 AM ET)
Recent SNAP Disruptions Highlight Urgent Need for Sustained Action Against Food Insecurity
PRNewswire (Wed, 26-Nov 11:00 AM ET)
PRNewswire (Tue, 25-Nov 3:47 PM ET)
AcariaHealth Highlights National Biosimilars Education Efforts with Three Events
PRNewswire (Thu, 20-Nov 2:45 PM ET)
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
Centene trades on the NYSE stock market under the symbol CNC.
As of December 23, 2025, CNC stock price declined to $39.60 with 3,199,293 million shares trading.
CNC has a beta of -0.04, meaning it tends to be less sensitive to market movements. CNC has a correlation of 0.00 to the broad based SPY ETF.
CNC has a market cap of $19.45 billion. This is considered a Large Cap stock.
Last quarter Centene reported $50 billion in Revenue and $.50 earnings per share. This beat revenue expectation by $2 billion and exceeded earnings estimates by $.68.
In the last 3 years, CNC traded as high as $83.61 and as low as $25.08.
The top ETF exchange traded funds that CNC belongs to (by Net Assets): VTI, VOO, IVV, VB, SPY.
CNC has underperformed the market in the last year with a return of -33.5%, while SPY returned +17.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in CNC shares. However, CNC has outperformed the market in the last 3 month and 2 week periods, returning +21.1% and +4.5%, while SPY returned +3.5% and +0.9%, respectively. This indicates CNC has been having a stronger performance recently.
CNC support price is $38.89 and resistance is $41.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNC shares will trade within this expected range on the day.